Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Up 5% on pre-market trades. $ZNOG
The bid is already moving higher. Don't loose your shares to early in the game. $ZNOG
Cancel your sell orders and watch shorts panick. Enjoy the ride.
Should be a good day for $ZNOG
Nice little action here today. $HENC
52 week high $0.80. $ZNOG.
The fact that it opened $0.04 cents higher today it telks me shorts are feeling threatened already. $ZNOG.
Hope it goes back on NASDAQ where it belongs, volume is impressive, it's already getting some well deserved attention.
Scarce or fierce ?
This baby is starting to look attractive again. $ZNOG
Dumpathon Olympics, this sucka is toast.
Regen BioPharma, Inc. to Initiate Development of its Modified mRNA anti-Cancer Vaccine Technology
SAN DIEGO, Feb. 11, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC:RGBP) and (OTC:RGBPP) is embarking on a development program to commercialize its modified mRNA anti-cancer vaccine targeting the Survivin protein. In the first phase of the development program, Regen will design and have experiments carried out that will form the initial series of pre-clinical studies required as part of an FDA IND submission.
The patented technology (patent issued in Aug, 2021) is a cellular vaccine that uses a modified mRNA molecule expressing peptides of Survivin which are exposed to dendritic cells. These dendritic cells are then matured and infused into the cancer patient's circulation where they are expected to home in on the cancer and destroy it. There are currently several clinical trials ongoing in the U.S. and Europe using Survivin as a vaccine for multiple different cancers which further supports this approach.
Survivin is the smallest member of the Inhibitor of apoptosis (IAP) family of proteins, involved in inhibition of apoptosis (a form of programmed cell death that occurs in multicellular organisms) and regulation of cell cycle. These functional attributes make Survivin a unique protein regulating cell proliferation and cell death. Expression of Survivin in tumors correlates with not only inhibition of apoptosis and a decreased rate of cell death, but also resistance to chemotherapy and aggressiveness of tumors. Therefore, Survivin is an important target for cancer vaccines and therapeutics.
"Although these are early steps, I am very pleased that we can begin the scientific and regulatory pathways of getting this newly patented technology into the clinic," says David Koos, CEO and Chairman of Regen. "This technology has been out-licensed for use in pancreatic cancer which leaves Regen dozens of other potential indications."
About Regen BioPharma Inc.:
Regen BioPharma, Inc. is a publicly traded biotechnology company (OTC:RGBP) and (OTC:RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
CONTACT INFORMATION
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-722-5505 Phone
+1-619-330-2328 Fax
http://www.regenbiopharma.com
david.koos@regenbiopharma.com
https://newsfilter.io/a/bd023e5795a93f1b74a3c9892d6c1425
It seems that everyone thinks 0009 PPS is too much to pay for this stock. After all the shares have been on sale and available for the last 3 trading days, LMFAO
This CEO wants every last penny from that tax return check.
That was short lived, just when you fill up the bucket with milk there's always that cow to tip it over.
I'm glad you can see the positive side in -6% today again a red day. CEO's love smart shareholders. I wish I had these many loyals in my crew. LMFAO
How do you feel about selling a ton today ? 100 mil shares dumped in 5 minutes.
I really missed this one and I even started this board SMH, thanks for bringing my attention to it, I forgot about this stock completely.
Is this company really proud of their stock trading in the trips ? SMFGDH
Welcome to Jet Token, see you at the bell. Take me high and don't let me down.
Wow, Dec 2022 forecast prediction is $19,000 PPS, no wonder they are unloading millions of shares, they only need 10 shares to join the millionaire club, they are actually doing peeps a favor, they do not all that money to themselves, they are actually sharing the wealth. LMFAO
It looks like there's more "buying" today. LMFAO
Average down you say ? 150 mil dumped at 001, plenty to average down.
I'm really not your problem, I'm sure you're smart enough to know who's robbing shareholders, call him and let him know how you feel, that would be wise.
There's only one Bezos, the rest of the OTC CEO's are nothing but Bozos, big difference, Bezos owns a rocket, Bozos rob your pocket.
Another crappy day, everything sold at 11 gets added back to 12, nice strategy. LMFAO
Plenty shares for all of you to average down...and down...and down some more
Buy the Dip and HODL, LMFAO
And as scheduled the dump begins before closing bell.
Major dump will wipe both bids at 12 and 11 before the bell.
It looked good, but that was before this bloodbath caused by your blood thirsty CEO.
90 mil shares traded and we're down 15%, LMFAO, but dilution it's not an issue here, it's "false", lol
With this buying power this stock should've been trading in the 30's already, yet here we are Mexican Standoff at 13.
If they could just chill a bit from this dilution, it's so obvious they want every penny before the sentiment runs out.
This CEO has a plan, but shareholders are not in his plan at all, just a means of raising funds...that's all, last one out turn the lights off.
Greedy CEO, that's no doubt in my mind, sad, sad little man.
It's up to you what you do, it seems a lot of shares are sold at this price, that means someone has no problem dumping at these levels in huge numbers, that should tell you something.
Every shell company has to start fresh, rinse and repeat.
You want me to lie to you and say it's going to a penny ? Not in this life time, can't even hold 0013, money runs out, shares don't, easy to print that.
AHFD SECURITY DETAILS
Share Structure
Market Cap Market Cap
11,161,677
01/05/2022
Authorized Shares
20,000,000,000
01/05/2022
Outstanding Shares
7,972,626,372
01/05/2022
Restricted
3,359,744,969
01/05/2022
Unrestricted
4,612,881,403
01/05/2022
Held at DTC
4,286,319,930
01/05/2022
Float
Not Available
The outstanding shares will become Float followed by a nice Reverse Split once at no bid.
Expect another 3 Bil share dump in the coming days.
LMFAO, not everyone is an infant like some pumpers on this board, facts are facts. The resistance at 13 and the force pushing this down is unreal....that is dilution, no if's or but's
Over 1,5 Bil shares traded in 5 days and the stock is still at 13, no dilution ? Think again, the numbers do not lie.